Mereo BioPharma Group plc MREO
$ 3.55
-2.2%
Annual report 2022
added 11-23-2024
Country |
Britain |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Denise Scots-Knight |
Employees in the company |
50 |
Shares |
- |
Market Cap[1] |
$ 660 M |
EBITDA (LTM) |
- |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.